SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 2, 1998
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission (IRS EMPLOYER
or incorporation) File Number) Identification)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (908) 542-2800
________________________________________________________________________________
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On February 2, 1998, the Company reported that it had filed a lawsuit on January
16, 1998, in the U.S. District Court in Newark, New Jersey against GenSci
Laboratories, Inc. and GenSci Regeneration Sciences, Inc. for patent
infringement. In the lawsuit, Osteotech accuses GenSci of violating claims of at
least one patent issued to Osteotech involving the Company's Grafton(R) DBM
process, by making, using, and/or selling the invention claimed in the patent
without permission or license from Osteotech. The GenSci products are marketed
under the names DynaGraft Gel and DynaGraft Putty.
Approximately two (2) weeks after Osteotech's filing, GenSci filed a suit in the
U.S. District Court for the Central District of California accusing Osteotech of
violating certain claims of two patents assigned to GenSci, by the processing of
Grafton(R) DBM Flex. Osteotech's Grafton(R) DBM Gel and Grafton(R) DBM Putty
products, which represent more than 90% of the Company's Grafton(R) DBM
revenues, are not involved in this law suit. The suit also contains claims
against Osteotech for alleged tortious interference with a business expectancy
of GenSci.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: February 5, 1998
OSTEOTECH, INC.
(Registrant)
By:/s/ Michael J. Jeffries
-----------------------------
MICHAEL J. JEFFRIES
Executive Vice President,
Chief Operating Officer,
Chief Financial Officer
and Secretary
